63 results
PRE 14A
BDTX
Black Diamond Therapeutics Inc
12 Apr 24
Preliminary proxy
4:48pm
, or ESG, strategy, initiatives, and policies, including matters related to environmental, health and safety, diversity and inclusion, and ethics … strategy and planning including product safety, human capital management, and ethics and compliance. These are among the areas of focus
8-K
EX-99.1
uzl 3rdav
12 Mar 24
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
7:17am
8-K
EX-99.2
8tkhqww71pzc8gfi
4 Jan 24
Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones
8:07am
8-K
EX-99.1
lwekmeosh2a 514
13 Dec 23
Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM
7:08am
8-K
1qmq4imo0k 28msptig
13 Dec 23
Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM
7:08am
8-K
EX-99.1
ocxsourgzxae1cyo
6 Nov 23
Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
7:10am
8-K
EX-99.1
q7hd6rl
11 Aug 23
Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:22am
8-K
EX-1.1
iifqp
30 Jun 23
Entry into a Material Definitive Agreement
4:03pm
424B5
jbieo3tki26z69
30 Jun 23
Prospectus supplement for primary offering
4:01pm
424B5
bkbbkz2u72p
29 Jun 23
Prospectus supplement for primary offering
6:02am
8-K
EX-99.1
odq pq0p0pnlzs
27 Jun 23
Regulation FD Disclosure
7:11am
8-K
jkt4kczgobsh8fps5vup
27 Jun 23
Regulation FD Disclosure
7:11am
8-K
EX-99.1
4mj wwrkf4zygk
9 May 23
Black Diamond Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:43am